Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
- Issued Date
- 2020
- Type
- Article
- Publisher
- ANNALS OF ONCOLOGY
- Language
- 영어
- ISSN
- 0923-7534
- Citation Volume
- 31
- Citation Number
- 8
- Citation Start Page
- 1030
- Citation End Page
- 1039
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.